Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02905825 · ClinicalTrials.gov registry record · Phase 3
Urea Breath Test (UBT) With Breath Hp System /BreathID Hp Lab System Pediatrics
A Phase 3 study, sponsored by Meridian Bioscience.
- Completed
- Registry status
- Phase 3
- Development phase
- 54
- Enrollment target
NCT02905825 is a Phase 3 study that has completed, run by Meridian Bioscience. The registered enrollment target is 54 participants.
The verdict
NCT02905825, a Phase 3 study, has completed, sponsored by Meridian Bioscience.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 54 participants
- Enrollment target
Study Summary
Clinical Study to Confirm Safety and Accuracy in Detection of H. pylori with 13C-Urea Breath Test using the BreathID® Hp and BreathID® Hp Lab Systems in the Pediatric Population
Interventions
- DEVICE BreathID® Hp System
- DRUG BreathID® Hp Lab System
- DIAGNOSTIC_TEST Stool Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-05-18 |
| Est. Completion | 2017-11-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02905825
The ClinicalTrials.gov registry entry for NCT02905825 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Meridian Bioscience, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which BreathID® Hp System is the first listed.
NCT02905825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02905825 about?
NCT02905825 is a clinical study titled "Urea Breath Test (UBT) With Breath Hp System /BreathID Hp Lab System Pediatrics". Clinical Study to Confirm Safety and Accuracy in Detection of H. pylori with 13C-Urea Breath Test using the BreathID® Hp and BreathID® Hp Lab Systems in the Pediatric Population
What is the current status of trial NCT02905825?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 54 participants. The study started on 2017-05-18. Estimated completion is 2017-11-05.
What interventions are being tested in trial NCT02905825?
The interventions under investigation include: BreathID® Hp System (DEVICE), BreathID® Hp Lab System (DRUG), Stool Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02905825?
This trial is sponsored by Meridian Bioscience, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.